Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Morphine recalled?

Yes — there is an active recall. 7 ongoing FDA recalls mention Morphine (189 total). Check the affected lots below.

Most common reason: Sterility / contamination (135 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Morphine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Morphine recalls in 2026

1 initiated in 2026, 189 in total — newest first
Class I · High risk

Morphine Sulfate Injection

Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

Ongoing Labeling / mix-up Fresenius Kabi USA, LLC D-0788-2026
Class I · High risk

Morphine Sulfate extended-Release Tablets

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Terminated Labeling / mix-up Bryant Ranch Prepack, Inc. NDC 63629-1089-01 D-1188-2022
Class I · High risk

Morphine Sulfate extended-Release Tablets

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Terminated Labeling / mix-up Bryant Ranch Prepack, Inc. D-1187-2022
Class I · High risk

Morphine Sulfate PF 25 mg/25mL

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

Terminated Labeling / mix-up STAQ Pharma, Inc. D-0634-2022
Class II · Moderate risk

Morphine Sulfate Injection

Defective container: Cracked vials leading to lack of sterility assurance

Terminated Packaging defect Fresenius Kabi USA LLC NDC 63323-452-01 D-0856-2021